. Author manuscript; available in PMC: 2020 May 1.

Published in final edited form as: J Affect Disord. 2019 Feb 26;250:65–70. doi: 10.1016/j.jad.2019.02.063

Table 1.

Demographic characteristics of all subjects and divided by responder/non-responder status in those 26 MDD subjects treated with open label sertraline for 8 weeks.

	All MDD patients (n=37)	Controls (n=41)	Statistical value	P-value	Non-responders (n=9)	Responders (n=17)	Statistical value	P-value
Age (±SD)	38.1±13.5	36.2±13.0	0.65	0.52	40.3±15.8	37.8±10.7	0.48	0.64
Sex % women (n)	64.9 (24)	61.0 (25)	0.13	0.72	77.8 (7)	58.8 (10)	0.28	0.59
BMI baseline (±SD)	25.0±4.5	24.9±4.9	0.13	0.89	28.4±5.1	24.0±3.7	2.53	0.02
Smoker % (n)	29.7 (11)	7.3 (3)	6.6	0.01	11.1 (1)	47.1 (8)	1.96	0.16
HDRS at baseline	19.4±2.6	N/A	N/A	N/A	19.1±1.8	18.9±2.4	0.18	0.86

P-values represent independent T-tests (continuous variables) or Pearson chi-square with continuity correction for comparisons between responders vs non-responders (categorical variables).